Docs Say Low T Therapy Carries Risk
The Endocrine Society released a statement that older men who are considering taking testosterone for …
Testosterone Therapy Linked To Heart Attack, Stroke and Death
Millions of men may be at risk for heart attack or stroke by using testosterone …
Essure Birth Control Complications On The Rise
Essure is a birth control device that is marketed as a form of permanent birth …
Big Pharma under Fire for Kickbacks to Docs
Trust and honesty are the cornerstones to a doctor-patient relationship. With so many doctors receiving …
Dietary Supplements Damage Liver
A recent study revealed a significant increase in liver damage related to dietary supplements. The …
FDA Advisory Committee Supports Approval of Gilead’s HIV Reducing Drug
The pharmaceutical industry may be on the verge of one of the greatest breakthrough’s that this generation has ever seen.
U.S. Health Regulators Issue New Restrictions For Gilenya, Novartis AG’s’ Multiple Sclerosis Pill
In December 2011, the FDA issued a Drug Safety Communication concerning a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod).
Plavix Linked with Internal Bleeding
Ten more people have died from Plavix, which had proven to be no better than aspirin against stroke even though it costs around 100 times more.
Military Announces Clinical Trials Set For PTSD Drugs
Our country has been at war for over a decade. Our soldiers are tired and weary, and many dealing with severe issues, such as Post Traumatic Stress Disorder (PTSD) from the things they have seen and experienced on the battlefield.
New Antidepressant Drug With Decreased Side Effects Could Be Available As Soon As Next Year
Soon there may be a new option available to those patients seeking medical help for depression, but are leery of traditional antidepressants due to the laundry list of side effects that have been linked to them, or who have had previous difficult experiences with the first line treatments.
What Is The Future For Lipitor?
Now that cholesterol reducing Lipitor has lost its’ patent, what is in store for the future of this blockbuster cash cow of a drug? Quite frankly….nothing
Plavix Patent Expiration Adds To Industry Troubles
Another major blockbuster medication has officially lost its patent as of May 17, 2012, resulting in the second major blow to the pharmaceutical industry in just a matter of months, since the expiration of Lipitor at the end of last year.
Report Raises Concerns Over Heart Defibrillator Leads
The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.
Overwhelming Recalls
Nowadays it seems next to impossible to keep up with the number of items we see being recalled daily here in the United States. From toys to baby formula, vehicle parts, and medications; the list is overwhelming at times to know what is safe and what isn’t.